145 related articles for article (PubMed ID: 37973666)
1. Compound Heterozygosity for Late-Onset Cardiomyopathy-Causative ALPK3 Coding Variant and Novel Intronic Variant Cause Infantile Hypertrophic Cardiomyopathy.
Poleg T; Eskin-Schwartz M; Proskorovski-Ohayon R; Aminov I; Dolgin V; Agam N; Jean M; Safran A; Freund O; Levitas A; Konstantino Y; Birk OS; Westreich R; Haim M
J Cardiovasc Transl Res; 2023 Dec; 16(6):1325-1331. PubMed ID: 37973666
[TBL] [Abstract][Full Text] [Related]
2. Phenotypic spectrum of ALPK3-related cardiomyopathy.
Al Senaidi K; Joshi N; Al-Nabhani M; Al-Kasbi G; Al Farqani A; Al-Thihli K; Al-Maawali A
Am J Med Genet A; 2019 Jul; 179(7):1235-1240. PubMed ID: 31074094
[TBL] [Abstract][Full Text] [Related]
3. Expanding the clinical and genetic spectrum of ALPK3 variants: Phenotypes identified in pediatric cardiomyopathy patients and adults with heterozygous variants.
Herkert JC; Verhagen JMA; Yotti R; Haghighi A; Phelan DG; James PA; Brown NJ; Stutterd C; Macciocca I; Leong K; Bulthuis MLC; van Bever Y; van Slegtenhorst MA; Boven LG; Roberts AE; Agarwal R; Seidman J; Lakdawala NK; Fernández-Avilés F; Burke MA; Pierpont ME; Braunlin E; Ḉağlayan AO; Barge-Schaapveld DQCM; Birnie E; van Osch-Gevers L; van Langen IM; Jongbloed JDH; Lockhart PJ; Amor DJ; Seidman CE; van de Laar IMBH
Am Heart J; 2020 Jul; 225():108-119. PubMed ID: 32480058
[TBL] [Abstract][Full Text] [Related]
4. [ALPK3 gene-related pediatric cardiomyopathy with craniofacial-skeletal features: a report and literature review].
Ding WW; Wang BZ; Han L; Li ZP; Zhang W; Wang H; Xiao YY
Zhonghua Er Ke Za Zhi; 2021 Sep; 59(9):787-792. PubMed ID: 34645221
[No Abstract] [Full Text] [Related]
5. Prevalence and phenotypes associated with ALPK3 null variants in a large French multicentric cohort: Confirming its involvement in hypertrophic cardiomyopathy.
Ader F; Jedraszak G; Janin A; Billon C; Buisson NR; Bloch A; Bensalah M; De Sandre-Giovannoli A; Goudal A; Marsili L; Cazeneuve C; Charron P; Millat G; Richard P;
Clin Genet; 2024 Jun; 105(6):676-682. PubMed ID: 38356193
[TBL] [Abstract][Full Text] [Related]
6. Generation of human induced pluripotent stem cell lines derived from four patients with a pathogenic ALPK3 variant associated with adult-onset hypertrophic cardiomyopathy (HCM).
Cheawsamoot C; Ramchandani R; Ameen M; Arthur Ataam J; Khongphatthanayothin A; Shotelersuk V; Karakikes I
Stem Cell Res; 2023 Dec; 73():103233. PubMed ID: 37944352
[TBL] [Abstract][Full Text] [Related]
7. Two New Cases of Hypertrophic Cardiomyopathy and Skeletal Muscle Features Associated with
Jorholt J; Formicheva Y; Vershinina T; Kiselev A; Muravyev A; Demchenko E; Fedotov P; Zlotina A; Rygkov A; Vasichkina E; Sejersen T; Kostareva A
Genes (Basel); 2020 Oct; 11(10):. PubMed ID: 33076350
[TBL] [Abstract][Full Text] [Related]
8. A Potential Oligogenic Etiology of Hypertrophic Cardiomyopathy: A Classic Single-Gene Disorder.
Li L; Bainbridge MN; Tan Y; Willerson JT; Marian AJ
Circ Res; 2017 Mar; 120(7):1084-1090. PubMed ID: 28223422
[TBL] [Abstract][Full Text] [Related]
9. Novel ALPK3 mutation in a Tunisian patient with pediatric cardiomyopathy and facio-thoraco-skeletal features.
Jaouadi H; Kraoua L; Chaker L; Atkinson A; Delague V; Levy N; Benkhalifa R; Mrad R; Abdelhak S; Zaffran S
J Hum Genet; 2018 Oct; 63(10):1077-1082. PubMed ID: 30046096
[TBL] [Abstract][Full Text] [Related]
10. A novel compound heterozygous variant in
Li T; Jin Y; Liu R; Hua Y; Zhou K; Luo S; Li Y; Zhang D
Front Cardiovasc Med; 2023; 10():1212417. PubMed ID: 37396576
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of Cardiomyopathy Caused by Variants in
Agarwal R; Wakimoto H; Paulo JA; Zhang Q; Reichart D; Toepfer C; Sharma A; Tai AC; Lun M; Gorham J; DePalma SR; Gygi SP; Seidman JG; Seidman CE
Circulation; 2022 Nov; 146(22):1674-1693. PubMed ID: 36321451
[TBL] [Abstract][Full Text] [Related]
12. The Involvement of
Dai J; Li K; Huang M; Sun Y; Liu H; Li Z; Chen P; Wang H; Wu D; Chen Y; Xiao L; Wei H; Li R; Peng L; Yu T; Wang Y; Wang DW
Front Med (Lausanne); 2022; 9():915649. PubMed ID: 35783621
[TBL] [Abstract][Full Text] [Related]
13. Genetic evaluation of cardiomyopathies in Qatar identifies enrichment of pathogenic sarcomere gene variants and possible founder disease mutations in the Arabs.
Al-Shafai KN; Al-Hashemi M; Manickam C; Musa R; Selvaraj S; Syed N; Vempalli F; Ali M; Yacoub M; Estivill X
Mol Genet Genomic Med; 2021 Jul; 9(7):e1709. PubMed ID: 34137518
[TBL] [Abstract][Full Text] [Related]
14. Alpha-protein kinase 3 (ALPK3) truncating variants are a cause of autosomal dominant hypertrophic cardiomyopathy.
Lopes LR; Garcia-Hernández S; Lorenzini M; Futema M; Chumakova O; Zateyshchikov D; Isidoro-Garcia M; Villacorta E; Escobar-Lopez L; Garcia-Pavia P; Bilbao R; Dobarro D; Sandin-Fuentes M; Catalli C; Gener Querol B; Mezcua A; Garcia Pinilla J; Bloch Rasmussen T; Ferreira-Aguar A; Revilla-Martí P; Basurte Elorz MT; Bautista Paves A; Ramon Gimeno J; Figueroa AV; Franco-Gutierrez R; Fuentes-Cañamero ME; Martinez Moreno M; Ortiz-Genga M; Piqueras-Flores J; Analia Ramos K; Rudzitis A; Ruiz-Guerrero L; Stein R; Triguero-Bocharán M; de la Higuera L; Ochoa JP; Abu-Bonsrah D; Kwok CYT; Smith JB; Porrello ER; Akhtar MM; Jager J; Ashworth M; Syrris P; Elliott DA; Monserrat L; Elliott PM
Eur Heart J; 2021 Aug; 42(32):3063-3073. PubMed ID: 34263907
[TBL] [Abstract][Full Text] [Related]
15. Molecular genetic and functional characterization implicate muscle-restricted coiled-coil gene (MURC) as a causal gene for familial dilated cardiomyopathy.
Rodriguez G; Ueyama T; Ogata T; Czernuszewicz G; Tan Y; Dorn GW; Bogaev R; Amano K; Oh H; Matsubara H; Willerson JT; Marian AJ
Circ Cardiovasc Genet; 2011 Aug; 4(4):349-58. PubMed ID: 21642240
[TBL] [Abstract][Full Text] [Related]
16. Tcap gene mutations in hypertrophic cardiomyopathy and dilated cardiomyopathy.
Hayashi T; Arimura T; Itoh-Satoh M; Ueda K; Hohda S; Inagaki N; Takahashi M; Hori H; Yasunami M; Nishi H; Koga Y; Nakamura H; Matsuzaki M; Choi BY; Bae SW; You CW; Han KH; Park JE; Knöll R; Hoshijima M; Chien KR; Kimura A
J Am Coll Cardiol; 2004 Dec; 44(11):2192-201. PubMed ID: 15582318
[TBL] [Abstract][Full Text] [Related]
17.
Çağlayan AO; Sezer RG; Kaymakçalan H; Ulgen E; Yavuz T; Baranoski JF; Bozaykut A; Harmanci AS; Yalcin Y; Youngblood MW; Yasuno K; Bilgüvar K; Gunel M
Cold Spring Harb Mol Case Stud; 2017 Sep; 3(5):. PubMed ID: 28630369
[TBL] [Abstract][Full Text] [Related]
18. A novel missense mutation in the myosin binding protein-C gene is responsible for hypertrophic cardiomyopathy with left ventricular dysfunction and dilation in elderly patients.
Konno T; Shimizu M; Ino H; Matsuyama T; Yamaguchi M; Terai H; Hayashi K; Mabuchi T; Kiyama M; Sakata K; Hayashi T; Inoue M; Kaneda T; Mabuchi H
J Am Coll Cardiol; 2003 Mar; 41(5):781-6. PubMed ID: 12628722
[TBL] [Abstract][Full Text] [Related]
19. A Pathogenic Variant in
Cheawsamoot C; Phokaew C; Chetruengchai W; Chantranuwat P; Puwanant S; Tongsima S; Khongphatthanayothin A; Shotelersuk V
Circ Genom Precis Med; 2020 Dec; 13(6):e003127. PubMed ID: 33191771
[No Abstract] [Full Text] [Related]
20. Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy.
Lakdawala NK; Thune JJ; Colan SD; Cirino AL; Farrohi F; Rivero J; McDonough B; Sparks E; Orav EJ; Seidman JG; Seidman CE; Ho CY
Circ Cardiovasc Genet; 2012 Oct; 5(5):503-10. PubMed ID: 22949430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
